Drug Type Contrast agent, Chemical drugs |
Synonyms Ferumoxtran-10 (USAN), AMI-227, AMI-227-CN + [7] |
Target- |
Mechanism Magnetic resonance imaging enhancers |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D04176 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lymphoma | NDA/BLA | - | - | |
Lymphoma | NDA/BLA | - | - | |
Adenosquamous Carcinoma | Phase 2 | US | 01 Sep 2007 | |
Adenosquamous Carcinoma | Phase 2 | JP | 01 Sep 2007 | |
Adenosquamous Carcinoma | Phase 2 | CA | 01 Sep 2007 | |
Adenosquamous Carcinoma | Phase 2 | KR | 01 Sep 2007 | |
Carcinosarcoma | Phase 2 | US | 01 Sep 2007 | |
Carcinosarcoma | Phase 2 | JP | 01 Sep 2007 | |
Carcinosarcoma | Phase 2 | CA | 01 Sep 2007 | |
Carcinosarcoma | Phase 2 | KR | 01 Sep 2007 |
Not Applicable | - | - | (Prostate Cancer Patients) | oxiumbbdul(rmqpgzgulp) = kgnhltxssw amcznfeohz (xbxlkwjuxd ) | - | 01 Oct 2005 | |
(Bladder Cancer Patients) | hkkpsrcjek(kfaystxqsf) = pqobfolnwv rwhggnicxs (tvkfyqvhcy, 21 - 47) | ||||||
Not Applicable | - | Combidex® (ferumoxtran-10) | dfdepgfrik(zrgsmkvhti) = okdawlzkem eybliwucat (nzetphyvsv, 1â6.3) View more | - | 01 Oct 2005 |